These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28412136)

  • 21. Probabilistic evaluation of target dose deterioration in dose painting by numbers for stage II/III lung cancer.
    Fontanarosa D; Witte M; Meijer G; Shakirin G; Steenhuijsen J; Schuring D; van Herk M; Lambin P
    Pract Radiat Oncol; 2015; 5(4):e375-82. PubMed ID: 25680996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robust dose-painting-by-numbers vs. nonselective dose escalation for non-small cell lung cancer patients.
    Petit SF; Breedveld S; Unkelbach J; den Hertog D; Balvert M
    Med Phys; 2021 Jun; 48(6):3096-3108. PubMed ID: 33721350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advanced kernel methods vs. Monte Carlo-based dose calculation for high energy photon beams.
    Fotina I; Winkler P; Künzler T; Reiterer J; Simmat I; Georg D
    Radiother Oncol; 2009 Dec; 93(3):645-53. PubMed ID: 19926153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective monte carlo dose calculations with limited beam weight information.
    Lindsay PE; El Naqa I; Hope AJ; Vicic M; Cui J; Bradley JD; Deasy JO
    Med Phys; 2007 Jan; 34(1):334-46. PubMed ID: 17278519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical introduction of Monte Carlo treatment planning: a different prescription dose for non-small cell lung cancer according to tumor location and size.
    van der Voort van Zyp NC; Hoogeman MS; van de Water S; Levendag PC; van der Holt B; Heijmen BJ; Nuyttens JJ
    Radiother Oncol; 2010 Jul; 96(1):55-60. PubMed ID: 20430461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of four-dimensional (4D) Monte Carlo dose calculation in real-time tumor tracking stereotatic body radiotherapy for lung cancers.
    Chan MK; Kwong DL; Ng SC; Tam EK; Tong AS
    Med Phys; 2012 Sep; 39(9):5479-87. PubMed ID: 22957615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metallic artifact mitigation and organ-constrained tissue assignment for Monte Carlo calculations of permanent implant lung brachytherapy.
    Sutherland JG; Miksys N; Furutani KM; Thomson RM
    Med Phys; 2014 Jan; 41(1):011712. PubMed ID: 24387504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric comparison of lung stereotactic body radiotherapy treatment plans using averaged computed tomography and end-exhalation computed tomography images: Evaluation of the effect of different dose-calculation algorithms and prescription methods.
    Mitsuyoshi T; Nakamura M; Matsuo Y; Ueki N; Nakamura A; Iizuka Y; Mampuya WA; Mizowaki T; Hiraoka M
    Med Dosim; 2016 Winter; 41(4):305-309. PubMed ID: 27623737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adaptive dose painting by numbers for head-and-neck cancer.
    Duprez F; De Neve W; De Gersem W; Coghe M; Madani I
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1045-55. PubMed ID: 20643512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beamlet based direct aperture optimization for MERT using a photon MLC.
    Henzen D; Manser P; Frei D; Volken W; Neuenschwander H; Born EJ; Joosten A; Lössl K; Aebersold DM; Chatelain C; Stampanoni MF; Fix MK
    Med Phys; 2014 Dec; 41(12):121711. PubMed ID: 25471958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative assessment of the accuracy of dose calculation using pencil beam and Monte Carlo algorithms and requirements for clinical quality assurance.
    Ali I; Ahmad S
    Med Dosim; 2013; 38(3):255-61. PubMed ID: 23558145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
    van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The registration of diagnostic versus planning fluorodeoxyglucose positron emission tomography/computed tomography in radiotherapy planning for non-small cell lung cancer.
    Yap ML; Vinod SK; Shon IA; Fowler A; Lin M; Gabriel G; Holloway LC
    Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):554-60. PubMed ID: 20605426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implementation of a Monte Carlo treatment planning system.
    Ma CM; Mok E; Kapur A; Pawlicki T; Findley D; Brain S; Forster K; Boyer AL
    Med Phys; 1999 Oct; 26(10):2133-43. PubMed ID: 10535630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    Nestle U; Kremp S; Schaefer-Schuler A; Sebastian-Welsch C; Hellwig D; Rübe C; Kirsch CM
    J Nucl Med; 2005 Aug; 46(8):1342-8. PubMed ID: 16085592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of dose painting of lung tumours using alanine/EPR dosimetry.
    Knudtsen IS; Svestad JG; Skaug Sande EP; Rekstad BL; Rødal J; van Elmpt W; Öllers M; Hole EO; Malinen E
    Phys Med Biol; 2016 Mar; 61(6):2243-54. PubMed ID: 26913997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
    Vinod SK; Kumar S; Holloway LC; Shafiq J
    J Med Imaging Radiat Oncol; 2010 Apr; 54(2):152-60. PubMed ID: 20518880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient-specific Monte Carlo-based dose-kernel approach for inverse planning in afterloading brachytherapy.
    D'Amours M; Pouliot J; Dagnault A; Verhaegen F; Beaulieu L
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1582-9. PubMed ID: 21075547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monte Carlo evaluation of RapidArc oropharynx treatment planning strategies for sparing of midline structures.
    Bush K; Zavgorodni S; Gagne I; Townson R; Ansbacher W; Beckham W
    Phys Med Biol; 2010 Aug; 55(16):4465-79. PubMed ID: 20668338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A clinical study of lung cancer dose calculation accuracy with Monte Carlo simulation.
    Zhao Y; Qi G; Yin G; Wang X; Wang P; Li J; Xiao M; Li J; Kang S; Liao X
    Radiat Oncol; 2014 Dec; 9():287. PubMed ID: 25511623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.